Ron Geller

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 17

Top Venues

PloS one

Nature communications

Virus evolution

PLoS biology

Universitat de València

Stanford University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat de València Jan 01 2017

Spain

Group Leader :: Institute for Integrative Systems Biology (I2SysBio)

Education History

Stanford University Sep 15 2002 - Apr 01 2008

United States

PHD :: Biology

Publications

Beatriz Álvarez-Rodríguez, Sebastian Velandia-Álvarez, Christina Toft, Ron Geller
Mapping mutational fitness effects across the coxsackievirus B3 proteome reveals distinct profiles of mutation tolerability. PLoS biology 22 (7) (2024)
Marina Rius-Salvador, Maria Jesús García-Múrria, Luciana Rusu, Manuel Bañó-Polo, Rubén León, Ron Geller, Ismael Mingarro, Luis Martinez-Gil
Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro. PloS one 19 (2) (2024)
Marc Carrascosa-Sàez, María-Carmen Marqués, Ron Geller, Santiago F Elena, Amal Rahmeh, Jeremy Dufloo, Rafael Sanjuán
Cell type-specific adaptation of the SARS-CoV-2 spike. Virus evolution 10 (1) (2024)
Marc Carrascosa-Sàez, María-Carmen Marqués, Ron Geller, Santiago F Elena, Amal Rahmeh, Jeremy Dufloo, Rafael Sanjuán
Cell type-specific adaptation of the SARS-CoV-2 spike. Virus evolution 10 (1) (2024)
Marc Carrascosa-Sàez, María-Carmen Marqués, Ron Geller, Santiago F Elena, Amal Rahmeh, Jeremy Dufloo, Rafael Sanjuán
Cell type-specific adaptation of the SARS-CoV-2 spike. Virus evolution 10 (1) (2024)
Marina Rius-Salvador, Maria Jesús García-Múrria, Luciana Rusu, Manuel Bañó-Polo, Rubén León, Ron Geller, Ismael Mingarro, Luis Martinez-Gil
Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro. PloS one 19 (2) (2024)
Beatriz Álvarez-Rodríguez, Sebastian Velandia-Álvarez, Christina Toft, Ron Geller
Mapping mutational fitness effects across the coxsackievirus B3 proteome reveals distinct profiles of mutation tolerability. PLoS biology 22 (7) (2024)
Marina Rius-Salvador, Maria Jesús García-Múrria, Luciana Rusu, Manuel Bañó-Polo, Rubén León, Ron Geller, Ismael Mingarro, Luis Martinez-Gil
Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro. PloS one 19 (2) (2024)
Beatriz Álvarez-Rodríguez, Javier Buceta, Ron Geller
Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3. Nature communications 14 (1) (2023)
Fernando Merwaiss, Enrique Lozano-Sanchez, João Zulaica, Luciana Rusu, Marta Vazquez-Vilar, Diego Orzaez, Guillermo Rodrigo, Ron Geller, José-Antonio Daròs
Plant virus-derived nanoparticles decorated with genetically encoded SARS-CoV-2 nanobodies display enhanced neutralizing activity. Plant biotechnology journal (2023)
Judit Serrat, Clara Francés-Gómez, David Becerro-Recio, Javier González-Miguel, Ron Geller, Mar Siles-Lucas
Antigens from the Helminth Fasciola hepatica Exert Antiviral Effects against SARS-CoV-2 In Vitro. International journal of molecular sciences 24 (14) (2023)
Nayara Panizo, Estela Giménez, Eliseo Albert, Joao Zulaica, Alicia Rodríguez-Moreno, Luciana Rusu, Elena Giménez-Civera, María Jesús Puchades, Luis D' Marco, Lorena Gandía-Salmerón, Ignacio Torres, Asunción Sancho, Eva Gavela, Miguel Gonzalez-Rico, Marco Montomoli, Carmen Maria Perez-Baylach, Begoña Bonilla, Camila Solano, Mª Fernanda Alvarado, Isidro Torregrosa, Boris Gonzales-Candia, María Jesús Alcaraz, Ron Geller, Jose Luis Gorriz Teruel, David Navarro
SARS-CoV-2-Spike Antibody and T-Cell Responses Elicited by a Homologous Third mRNA COVID-19 Dose in Hemodialysis and Kidney Transplant Recipients. Microorganisms 10 (11) (2022)
Florian Mattenberger, Victor Latorre, Omer Tirosh, Adi Stern, Ron Geller
Globally defining the effects of mutations in a picornavirus capsid. eLife 10 (2021)
Paula Ruiz-Rodriguez, Clara Francés-Gómez, Álvaro Chiner-Oms, Mariana G López, Santiago Jiménez-Serrano, Irving Cancino-Muñoz, Paula Ruiz-Hueso, Manuela Torres-Puente, Maria Alma Bracho, Giuseppe D'Auria, Llúcia Martinez-Priego, Manuel Guerreiro, Marta Montero-Alonso, María Dolores Gómez, José Luis Piñana, null null, Fernando González-Candelas, Iñaki Comas, Alberto Marina, Ron Geller, Mireia Coscolla
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2. mBio (2021)
Ron Geller, Sebastian Pechmann, Ashley Acevedo, Raul Andino, Judith Frydman
Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation. Nature communications 9 (1) (2018)
Victor Latorre, Florian Mattenberger, Ron Geller
Chaperoning the Mononegavirales: Current Knowledge and Future Directions. Viruses 10 (12) (2018)
Ron Geller, Úrsula Estada, Joan B Peris, Iván Andreu, Juan-Vicente Bou, Raquel Garijo, José M Cuevas, Rosario Sabariegos, Antonio Mas, Rafael Sanjuán
Highly heterogeneous mutation rates in the hepatitis C virus genome. Nature microbiology 1 (7) (2016)
Ron Geller, Pilar Domingo-Calap, José M Cuevas, Paola Rossolillo, Matteo Negroni, Rafael Sanjuán
The external domains of the HIV-1 envelope are a mutational cold spot. Nature communications 6 (2015)

Ron Geller.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ron Geller